Effect of Tissue Inhibitors of Metalloproteinases and Matrix Metalloproteinases on Capsular Formation Around Smooth and Textured Silicone Gel Implants
- 199 Downloads
Capsular contracture is one of the most distressing complications after cosmetic breast augmentation. Evidence suggests that matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) may play a key role in the onset or progression of several fibrotic disorders. In this study we used quantitative reverse-transcription PCR methodology to profile the expression of TIMP-1, TIMP-2, MMP-2, and MMP-9 in the tissue of patients with capsular contracture after breast augmentation with smooth and textured silicone breast implants.
The study included 20 female patients (average age = 37 ± 15 years) with capsular contracture after bilateral subglandular cosmetic breast augmentation with smooth silicone implants. Ten patients developed grade II capsule contracture, 8 grade III contracture, and 1 grade IV contracture. Twenty other female patients (average age = 41 ± 9 years) with capsular contracture after breast augmentation with textured silicone implants were also included (Baker grade II = 10 patients, grade III = 8, grade IV = 2). Expression of mRNA in capsular tissue was calculated using a relative quantification method (Pfaffl). Statistical analysis was performed using the Mann-Whitney test. The level of significance was considered to be p < 0.05.
The expression of MMP-2 was significantly increased in tissue of patients with textured implants and capsular contracture grades II and III/IV in comparison to grade I (p < 0.05). In comparison to grade I, the capsular tissue from patients with Baker II and III/IV fibrosis showed a significant increase for TIMP-1 and TIMP-2 (p < 0.05) in both smooth and textured silicone implants. The expression was significantly higher in tissue from patients with severe contracture (Baker III/IV) and smooth silicone implants compared with that in tissue from patients with textured implants (p < 0.05).
The decrease in MMP-to-TIMP expression can cause increased synthesis and deposition of collagen surrounding alloplastic breast implants, leading to a profibrotic state. The higher expression of TIMPs in capsular tissue of patients with smooth silicone gel implants might be a reason for the observed higher rates of capsular contracture. In the future, a nonoperative treatment that decreases TIMPs but increases the activity of MMPs may be an appropriate therapy for patients with capsular contracture.
KeywordsBreast augmentation Smooth silicone implants Textured silicone implants Capsular contracture Matrix metalloproteinases Tissue inhibitors of metalloproteinases
The authors hereby certify that, to the best of their knowledge, no financial support or benefits have been received by any of them, by any member of their immediate families, or by any individual or entity with whom or with which they have a significant relationship from any commercial source that is related directly or indirectly to the scientific work that is reported on in the article.
- 1.Bostwick J (2000) Tissue expansion reconstruction. In: Bostwick J (ed) Plastic and reconstructive breast surgery, vol 2. Quality Medical Publishing, St. Louis, pp 811–866Google Scholar
- 24.Brew K, Dinakarpandian D, Nagase H (2002) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283Google Scholar
- 25.Ravanti L, Kahari VM (2001) Matrix metalloproteinases in wound repair. Int J Mol Med 6:391–407Google Scholar
- 38.Mao Sl, Gao WC (2008) Capsular contracture in breast augmentation with textured versus smooth mammary implants: a systematic review. Zhonghua Zheng Xing Wai Ke Za Zhi 24:71–74Google Scholar
- 40.Maxwell GP, Lugston PA (1997) Management of complications following augmentation mammaplasty. In: Georgeade GS, Riefkohl R, Levin LS (eds) Georgeade plastic, maxillofacial and reconstructive surgery, 3rd edn. Williams & Wilkins, BaltimoreGoogle Scholar
- 45.Ulrich D, Lichtenegger F, Eblenkamp M, Repper D, Pallua N (2004) Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with TRILUCENT breast implants. Plast Reconstr Surg 114:229–236PubMedCrossRefGoogle Scholar
- 49.Tarlton JF, Meagher P, Brown RA et al (1998) Mechanical stress in vitro induces increased expression of MMPs 2 and 9 in excised Dupuytren’s disease tissue. J Hand Surg [Br] 23:297–302Google Scholar